U.S. Pharmaceutical Industry Seen to Focus on COVID-19 Treatments Amid Competitive Environment
ArchIntel
JUNE 2, 2021
During his over four years with the company, he provided strategic insights and in-depth analysis about the oncology and rheumatology markets. Earlier in his career, Gunduz worked as a research scientist at the NYU School of Medicine. The post U.S.
104 
Let's personalize your content